M Ginsbourg, M Musset, J L Misset, O Genty, G Mathé
{"title":"鉴定骨髓中乳腺转移细胞作为微小残留疾病的标志物及其增殖指数作为预后因素——单克隆抗体免疫细胞学研究","authors":"M Ginsbourg, M Musset, J L Misset, O Genty, G Mathé","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":77903,"journal":{"name":"Supplement ... to the journal Medical oncology and tumor pharmacotherapy","volume":"1 ","pages":"51-4"},"PeriodicalIF":0.0000,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.\",\"authors\":\"M Ginsbourg, M Musset, J L Misset, O Genty, G Mathé\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":77903,\"journal\":{\"name\":\"Supplement ... to the journal Medical oncology and tumor pharmacotherapy\",\"volume\":\"1 \",\"pages\":\"51-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1988-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Supplement ... to the journal Medical oncology and tumor pharmacotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Supplement ... to the journal Medical oncology and tumor pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.